Benzodizapines Test Strips
A class of pharmacopoeia categorized according to their anti-anxiety, sedative, and hypnotic properties, benzodiazepines are one of the most commonly prescribed depressant medications in the US. Considered Schedule IV drugs under the Controlled Substances Act, benzodiazepine dependence develops rapidly with these highly addictive prescription medications.
Standard benzodiazepine urine drug tests test for the most common benzodiazepines including Librium, Xanax, Valium, Ativan, and Klonopin. Because benzodiazepines are extensively metabolized in the liver, it is not possible to test for the presence of parent compounds. Instead, 12 Panel Medical benzodiazepine urine test trips use immunoassay technology to test for the presence of a number of the most common benzodiazepine metabolites as well as related compounds.
Benzodiazepine urine drug tests from 12 Panel Medical are 99% accurate, rapid results drug tests that provide a qualitative and definitive “positive” or “negative” results within five minutes of testing the urine specimen. With an internal control system and 100% compliance with SAMHSA guidelines for cutoff concentrations of various benzodiazepines, these urine test strips are intended for clinical use but easy enough for use in the home.
As one of the most commonly prescribed classes of pharmaceuticals in the US, benzodiazepine abuse is widespread. Benzodiazepines are a highly addictive category of drugs that can quickly lead to physical dependence and addiction. When combined with alcohol or the concomitant use of other CNS depressant drugs, the side effects of benzodiazepines are potentially fatal.
Benzodiazepines are administered orally and rapidly distributed throughout the body. This class of pharmaceuticals is extensively metabolized by the liver, leaving very little metabolite concentrations available for detection by a benzodiazepine drug test. Instead, they are slowly excreted through the urine as a pharmacologically inactive conjugated metabolite.
Urine drug tests using immunoassay methods are one of the most common methods of detecting benzodiazepine dependence. Compliant with cutoff levels determined by SAMHSA and accurate within 1%, they can be used for the qualitative detection of abuse versus therapeutic use.
12 Panel Medical benzodiazepine urine drug tests offer detection catalogues for long acting benzodiazepines up to 10 days following ingestions. For shorter-acting benzodiazepines, detection windows may be as long as two days.
It should be noted that benzodiazepines are a complex and diverse group of pharmaceuticals. Urine drug testing with immunoassay technology is limited in its ability to determine the parent drug(s) causing a positive result.
Cutoff concentrations for benzodiazepines are determined by SAMHSA. 12 Panel Medical uses these standards as guidelines for the cutoff concentrations that determine the ‘negative’ or ‘positive’ result of the benzodiazepine drug test.
Cutoff concentrations are expressed as nanograms per milliliter (ng/ml). Should a specimen exceed the 300 ng/ml cutoff level, the test strip will display a negative result
A sample urine specimen must be collected from the donor for testing. When the urine specimen is ready for testing, the operator will remove the benzodiazepine drug test from the protective packaging.
The testing strip may be damaged by extended exposure to light and air. Do not remove the strip until ready to perform the test to ensure the most reliable results. If the testing strip was removed from packaging more than 1 hour prior to testing, the results should not be interpreted.
Do not touch the strip membrane. Bacteria from hands and surfaces may contaminate the testing strip and invalidate results.
Hold the benzodiazepine drug test where the product name is printed. Carefully place the testing strip membrane into the cup, in a vertical position. Do not immerse the strip past the MAX line on the testing strip.
Allow the strip to absorb as much of the sample as possible, immersing the membrane in the specimen for at least 10 to 15 seconds. You might notice color moving across the strip, but the results cannot be read before five minutes. Do not interpret results after 10 minutes.
If the specimen contains more than the pre-determined cutoff levels, the result is positive. This is indicated by one colored band in the control region and no colored band in the test region. Positive results should be sent to a toxicology laboratory for confirmation.
A negative result is indicated by one colored band in the control region, and one colored band in the test region. A negative result indicates that the specimen does not reach the cutoff levels.
If no colored band appears in the control indicator of the test strip, the result is invalid. The test must be performed again. If the problem persists, you may contact your local distributor.